Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam
评估越南 PrEP 使用者中性传播感染筛查和淋病奈瑟菌耐药性
基本信息
- 批准号:10389089
- 负责人:
- 金额:$ 22.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-05 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAffectAnatomyAntibiotic susceptibilityAntibioticsAntimicrobial ResistanceAntimicrobial susceptibilityAzithromycinCephalosporinsCharacteristicsChlamydia trachomatisCiprofloxacinDataDevelopmentDiagnosticDiagnostic testsElementsEpidemicFoundationsFrequenciesFutureGeneral PopulationGenesGeneticGenetic MarkersGenitourinary systemGenomicsGuidelinesHIVHIV InfectionsHIV riskHealthIncidenceIndividualInfectionKnowledgeLocal GovernmentManuscriptsMedicalMeta-AnalysisModelingMultiple Anatomic SitesNeisseriaNeisseria gonorrhoeaeOropharyngealPenicillin ResistancePhasePredispositionPregnant WomenPrevalencePublishingRapid screeningReportingResearch PersonnelResistanceRiskRisk FactorsSexually Transmitted DiseasesSiteSyphilisTest ResultTestingTrainingUnited NationsUniversitiesVietnamWorkWorld Health Organizationacceptability and feasibilitycohortdata sharingdrug-resistant gonorrheagenome sequencinggenomic locusglobal healthglobal health emergencyhigh risk meninsightlow and middle-income countriesmen who have sex with menpre-exposure prophylaxisprogramsrectalresistant strainroutine screeningsatisfactionscreeningtooltransgender womentransmission processwhole genomewillingness to pay
项目摘要
PROJECT ABSTRACT
Men who have sex with men (MSM) are at higher risk for HIV and sexually transmitted infections (STIs)
that increase HIV risk, such as Neisseria gonorrhoeae and Chlamydia trachomatis. HIV pre-exposure
prophylaxis (PrEP) users—many of whom are MSM—are also at increased risk for STIs. U.S. guidelines
recommend that PrEP users undergo frequent screening in multiple anatomic sites (pharyngeal, urogenital,
and rectal) for asymptomatic infections. However, lower- and middle-income countries (LMICs) lack such
guidelines, resulting in missed opportunities for STI screening and treatment among LMIC PrEP users.
Antimicrobial resistance (AMR) in N. gonorrhoeae is an urgent global health threat and the prevalence is
highest in LMICs, where access to diagnostics is limited. In particular, the Western Pacific Region, which
includes the LMIC of Vietnam, has seen increasing spread of AMR in N. gonorrhoeae, which has spread
worldwide. Major gaps exist in understanding the drivers of AMR in N. gonorrhoeae in LMICs.
In this study, investigators from UCLA and Hanoi Medical University will investigate the acceptability and
feasibility of C. trachomatis and N. gonorrhoeae screening among MSM and transwomen engaged in an HIV
PrEP program in Hanoi, Vietnam. We hypothesize that screening will be acceptable and feasible. We will also
investigate risk factors for AMR and genomic relationships between commensal Neisseria and N. gonorrhoeae
at genetic loci associated with AMR, hypothesizing that recent antibiotic use is a risk factor for AMR.
AIM 1: (a) To determine the distribution of anorectal, pharyngeal, and urogenital C. trachomatis and N.
gonorrhoeae infections among MSM and transgender women PrEP users (n=1,300) in Hanoi, Vietnam and (b)
To evaluate the acceptability and feasibility, including willingness to pay, of rapid, triple-site testing.
AIM 2: (a) To collect, culture, and perform antibiotic susceptibility testing on N. gonorrhoeae and oropharyngeal
Neisseria species to investigate the prevalence and correlates of AMR and b) To perform whole-genome
sequencing on pairs of N. gonorrhoeae and Neisseria species isolated from within the same individual to
investigate relationships within genes associated with antimicrobial resistance in N. gonorrhoeae.
This two-year project has four phases. Phase 1 will last three months and will involve development of study
materials, planning, and training. Phase 2 will last one year and will evaluate acceptability and feasibility of C.
trachomatis and N. gonorrhoeae screening. Phase 3 will last 9 months and will involve antimicrobial
susceptibility testing and whole genome sequencing. Phase 4 will last 3 months and will involve dissemination
of findings through manuscripts, presentations, and sharing of data with local government and health agencies.
Findings from the study will form the foundation for a future R01-proposal to investigate the impact of routine
screening and treatment of STIs on the development of antimicrobial resistance is N. gonorrhoeae.
项目摘要
男男性行为者(MSM)感染艾滋病毒和性传播感染的风险更高
增加艾滋病风险,如淋病奈瑟菌和沙眼衣原体。艾滋病毒暴露前
预防性治疗(PrEP)的使用者--其中许多是MSM--也面临着增加的性传播感染风险。美国指南
建议PrEP使用者在多个解剖部位(咽,泌尿生殖,
和直肠)用于无症状感染者。然而,低收入和中等收入国家缺乏这种能力,
指南,导致LMIC PrEP用户错过了STI筛查和治疗的机会。
耐药性(AMR)的N。淋病是一种紧迫的全球健康威胁,
在获得诊断的机会有限的中低收入国家,这一比例最高。特别是西太平洋区域,
包括越南的LMIC在内,已经看到N.淋病,它已经蔓延到
国际吧在了解N.淋病在中低收入国家
在这项研究中,来自加州大学洛杉矶分校和河内医科大学的研究人员将调查
C的可行性。沙眼衣原体和N.在从事艾滋病毒感染的男男性接触者和变性妇女中进行淋病筛查
越南河内的PrEP计划。我们假设筛查是可接受的和可行的。我们还将
研究耐药性危险因素以及耐药奈瑟菌和奈瑟菌之间的基因组关系。淋病
在与AMR相关的遗传位点,假设最近使用抗生素是AMR的危险因素。
目的1:(a)确定肛门直肠、咽部和泌尿生殖道念珠菌的分布。沙眼衣原体和N.
越南河内的MSM和变性女性PrEP使用者(n = 1,300)中的淋病感染和(B)
评估快速三点检测的可接受性和可行性,包括支付意愿。
目的2:(a)收集、培养和药敏试验。淋病和口咽
奈瑟氏菌属物种,以研究AMR的患病率和相关性,和B)进行全基因组测序。
对N.淋病和奈瑟菌属物种分离自同一个人,
研究与N.淋病
这个为期两年的项目分为四个阶段。第一阶段将持续三个月,将涉及研究的发展
材料、规划和培训。第二阶段将持续一年,将评估C。
沙眼衣原体和N.淋病筛查第三阶段将持续9个月,
敏感性测试和全基因组测序。第四阶段将持续3个月,
通过手稿、演示以及与当地政府和卫生机构共享数据来收集和分析研究结果。
这项研究的结果将为未来的R01提案奠定基础,以调查日常生活的影响。
筛选和治疗性传播感染对耐药性的发展是N。淋病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey David Klausner其他文献
Jeffrey David Klausner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey David Klausner', 18)}}的其他基金
Pilot study of linezolid for early syphilis treatment
利奈唑胺治疗早期梅毒的初步研究
- 批准号:
10575509 - 财政年份:2022
- 资助金额:
$ 22.08万 - 项目类别:
Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam
评估越南 PrEP 使用者中性传播感染筛查和淋病奈瑟菌耐药性
- 批准号:
10343849 - 财政年份:2021
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒疗效的临床试验
- 批准号:
10417271 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10555240 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10385627 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical trial comparing the effectiveness of cefixime versus penicillin G for treatment of early syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒有效性的临床试验
- 批准号:
10079905 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10322132 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒疗效的临床试验
- 批准号:
10652990 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒疗效的临床试验
- 批准号:
10392825 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical study of STI screening to prevent adverse birth and newborn outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10082426 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 22.08万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 22.08万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 22.08万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 22.08万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 22.08万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 22.08万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 22.08万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 22.08万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 22.08万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 22.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists